Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Active surveillance (AS) is emerging as an alternative approach to limit the risk of overtreatment and impairment of quality of life (QoL) in patients with low-risk localised prostate cancer. Although most patients report high levels of QoL, some men may be distressed by the idea of living with untreated cancer. Objective: To identify factors associated with poor QoL during AS. Design, setting, and participants: Between September 2007 and March 2012, 103 patients participated in the Prostate Cancer Research International Active Surveillance (PRIAS) QoL study. Mental health (Symptom Checklist-90), demographic, clinical, and decisional data were assessed at entrance in AS. Health-related QoL (HRQoL) Functional Assessment of Cancer Therapy-Prostate version and Mini-Mental Adjustment to Cancer outcomes were assessed after 10 mo of AS. Outcome measurements and statistical analysis: Multivariate logistic regression models were used to identify predictors of low (18 core specimens (OR: 0.89; p = 0.029) were predictors of better QoL. Limitations of this study were the small sample size and the lack of a control group. Conclusions: Factors predicting poor QoL were lack of a partner, impaired mental health, recent diagnosis, influence of clinicians and lower number of core samples taken at diagnostic biopsy. Educational support from physicians and emotional/social support should be promoted in some cases to prevent poor QoL.

Original languageEnglish
Pages (from-to)30-36
Number of pages7
JournalEuropean Urology
Volume64
Issue number1
DOIs
Publication statusPublished - Jul 2013

Keywords

  • Active surveillance
  • Adjustment to cancer
  • Coping
  • Prostate cancer
  • Quality of life

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance'. Together they form a unique fingerprint.

Cite this